The Anti-GPC3 Targeted Therapies Market is rapidly evolving as new-generation cancer treatments focus on glypican-3 (GPC3), a protein linked with aggressive tumor growth in hepatocellular carcinoma (HCC). As liver cancer prevalence continues to climb worldwide, GPC3-targeting drugs are emerging as vital assets within the precision oncology pipeline. The Role of GPC3 in Cancer Glypican-3 plays...